Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051654
Filing Date
2020-11-06
Accepted
2020-11-06 07:00:59
Documents
87
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eypt-10q_20200930.htm   iXBRL 10-Q 2672457
2 EX-10.1 eypt-ex101_120.htm EX-10.1 174753
3 EX-31.1 eypt-ex311_8.htm EX-31.1 15777
4 EX-31.2 eypt-ex312_7.htm EX-31.2 15719
5 EX-32.1 eypt-ex321_6.htm EX-32.1 5543
6 EX-32.2 eypt-ex322_9.htm EX-32.2 5619
  Complete submission text file 0001564590-20-051654.txt   10248179

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA eypt-20200930.xsd EX-101.SCH 80202
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eypt-20200930_cal.xml EX-101.CAL 54682
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eypt-20200930_def.xml EX-101.DEF 278374
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eypt-20200930_lab.xml EX-101.LAB 553094
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eypt-20200930_pre.xml EX-101.PRE 443048
12 EXTRACTED XBRL INSTANCE DOCUMENT eypt-10q_20200930_htm.xml XML 1878760
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51122 | Film No.: 201292363
SIC: 3826 Laboratory Analytical Instruments